Dr Nick Lynch
Nick has worked in life science data and informatics for over three decades. Prior to leading teams in R&D informatics at AstraZeneca, he worked in biotech and also in computational modelling companies after his PhD.
Nick has been involved in various cross industry / pre-competitive activities and co-founded the Pistoia Alliance in 2009.
He also founded Curlew Research 12 years ago, supporting biopharma with their FAIR data, ML/AI and informatics challenges, plus knowledge graphs.
Nick has led the data team for ASAP Discovery Consortium (AI-driven Structure-enabled Antiviral Platform) working on pandemic preparedness using Open Science.
Throughout his projects, the business change has been a key element – as important as the technology, data and process.
ArticleAI’s real value in drug discovery may be choosing the right experiment
AI is becoming more capable, but its value still depends on the data, questions and decisions behind it. Where is it genuinely improving drug discovery and where do the limitations remain?